National Drug Code (NDC) Database
Alkermes, Inc.
-
NDC:
65757-728
-
Nonproprietary Name:
risperidone
-
Dosage Form:
INJECTION, SUSPENSION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
50 mg/2mL
-
Substance:
RISPERIDONE
-
Start Marketing Date:
2003-10-29
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Allergan, Inc.
-
NDC:
61874-617
-
Nonproprietary Name:
cariprazine
-
Dosage Form:
CAPSULE, GELATIN COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
0.75 mg/1
-
Substance:
CARIPRAZINE
-
Start Marketing Date:
2025-11-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Alliance Medical Products Inc. (dba Siegfried Irvine)
-
NDC:
71991-016
-
Nonproprietary Name:
PERFLUORHEXYLOCTANE
-
Dosage Form:
SOLUTION/ DROPS
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
1.338 g/mL
-
Substance:
PERFLUOROHEXYLOCTANE
-
Start Marketing Date:
2024-03-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Alloga Logística España S.L.
-
NDC:
84586-112
-
Nonproprietary Name:
Respiratory Syncytial Virus Vaccine
-
Dosage Form:
SUSPENSION
-
Product Type:
VACCINE
-
Strength:
50 ug/.5mL
-
Substance:
RNA-100-AR02
-
Start Marketing Date:
2024-05-31
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
60468-003
-
Nonproprietary Name:
BUMETANIDE
-
Dosage Form:
TABLET
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
2 mg/1
-
Substance:
BUMETANIDE
-
Start Marketing Date:
2015-08-10
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Allsino Pharmaceutical Co., Ltd.
-
NDC:
84536-378
-
Nonproprietary Name:
Salcaprozate Sodium
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
SALCAPROZATE SODIUM
-
Start Marketing Date:
2025-01-20
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Almirall, LLC
-
NDC:
16110-247
-
Nonproprietary Name:
sarecycline hydrochloride
-
Dosage Form:
TABLET, COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
150 mg/1
-
Substance:
SARECYCLINE HYDROCHLORIDE
-
Start Marketing Date:
2019-01-04
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Almon Healthcare Private Limited
-
NDC:
84241-113
-
Nonproprietary Name:
Nicotinamide Adenine Dinucleotide
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
NICOTINAMIDE ADENINE DINUCLEOTIDE
-
Start Marketing Date:
2024-11-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
68625-025
-
Nonproprietary Name:
frovatriptan succinate
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
2.5 mg/1
-
Substance:
FROVATRIPTAN SUCCINATE
-
Start Marketing Date:
2001-08-11
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
57315-216
-
Nonproprietary Name:
sumatriptan succinate
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
100 mg/1
-
Substance:
SUMATRIPTAN SUCCINATE
-
Start Marketing Date:
2020-09-17
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.